MediPharm Labs Corp. (OTCQX: MEDIF) (TSX:LABS) (FSE:MLZ) Q2 2022 revenue declined 14%, to CA$4.36 million ($3,37 million), compared to revenue of CA$5.07 million in Q2 2021.
MediPharm Labs Corp. (OTC: MEDIF) a pharmaceutical company specializing in precision-based cannabinoids, announced on Thursday its financial results for the Fourth Quarter and Full-Year that ended on December 31, 2021.
2021 Highlights
CBD-based pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) has completed a Drug Master File (DMF) process for CBD Active Pharmaceutical Ingredient (API) for the US Federal Drug Administration (FDA).
The Best Daily Overview Of The Cannabis Space
CV Sciences Announces New Distribution Agreement with GNC. $CVSI
Massachusetts cannabis prices continue to fall
Kentucky GOP Sen. Damon Thayer: "Medical cannabis is a slippery slope for recreational marijuana.”
MediPharm Labs Announces Board Shake-Up
CBD-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) announced changes to its board of directors Tuesday.
Avicanna Inc. (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, has successfully expanded its Rho Phyto-branded medical cannabis products into the Car
Former Crop One and Sensei Ag CEO Sonia Lo Joins Urban-Gro’s Board Of Directors
Urban-gro, Inc. (NASDAQ: UGRO) announced Thursday that Sonia Lo agreed to join the company’s board of directors.